Request availability and a quotation for your required quantity and destination.
| Product | Tadalafil 20 mg – Tadasoft Tablet |
|---|---|
| Categories | Cialis / Tadalafil, Erectile Dysfunction |
| Availability | Confirmed on enquiry |
Product listing is not a recommendation to use this medicine. Prescription and destination requirements apply where relevant.
Listed composition: Tadalafil 20 mg. Dosage form: Chewable oral tablet (verify pack). Product identity, strength and authenticity must be verified against manufacturer’s pack before any supply.
Tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor prescribed for erectile dysfunction and, in some formulations and markets, other clinician-assessed indications. Sexual stimulation is necessary for an erectile response. This is not a medical recommendation to use a particular dose.
Do not take tadalafil with nitrates or riociguat. Discuss heart conditions, low blood pressure, alpha-blockers, liver or kidney disease and drug interactions with your prescriber. Seek urgent medical help for sudden loss of vision or hearing, chest pain, or an erection lasting more than four hours. Do not combine tadalafil with sildenafil or vardenafil unless instructed by a specialist.
View all Tadalafil products and brands · Browse Erectile Dysfunction catalogue
The source lists tadalafil 20 mg. Confirm against the manufacturer’s original package.
No. Only a clinician can assess suitability; higher-strength products may exceed standard labelled dosing.
No. The combination can lead to dangerous low blood pressure.
Do not combine PDE5 inhibitors without explicit specialist guidance.
Consult a medical professional and follow applicable prescription and country-specific import requirements.
International enquiry: Availability, authenticity, prescribing requirements and import legality must be verified. A catalogue listing does not guarantee supply.
Related patient guide: Read sildenafil versus tadalafil: timing, duration and safety. This link is educational, not a dosing recommendation. A prescriber should review suitability, and PDE5 inhibitors must not be combined with nitrate medicines.